The largest database of trusted experimental protocols

Atg5 sirna

Manufactured by Santa Cruz Biotechnology
Sourced in United States

ATG5 siRNA is a short interfering RNA (siRNA) that targets the ATG5 gene, which is involved in the autophagy process. Autophagy is a cellular mechanism responsible for the degradation and recycling of damaged or unnecessary cellular components. The ATG5 siRNA can be used to study the role of autophagy in various cellular processes and disease models.

Automatically generated - may contain errors

10 protocols using atg5 sirna

1

siRNA Transfection for HT22 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For siRNA transfection, HT22 cells were plated in 60 mm dishes at 5 x
105 cells/dish and 20 pmol ATG5 siRNA (#sc-41446 mouse; #sc41445-
human) or HIF1α siRNA (#sc-35562) from Santa Cruz Biotechnology or
control siRNA (#1027280) from Qiagen, were used along with RNAi max (Invitrogen)
according to the manufacturer’s instructions.
+ Open protocol
+ Expand
2

ATG5 siRNA Knockdown in HT22 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For siRNA transfections, HT22 cells were plated in 60 mm dishes at 5 × 105 cells/dish. For transfection, 166 pmol ATG5 siRNA (#sc-41446) or control siRNA (#sc-37007), all from Santa Cruz Biotechnology (Santa Cruz, CA) was used along with RNAiMAX (Invitrogen) according to the manufacturer's instructions.
+ Open protocol
+ Expand
3

Targeted siRNA Delivery for Liver Protection

Check if the same lab product or an alternative is used in the 5 most similar protocols
ATG5 siRNA (Santa Cruz, CA, USA) was premixed with mannose-conjugated polymers (Polyplus transfection, USA) at a ratio specified by the manufacture and was administered by tail vein injection (siRNA 2 mg/kg) 4 h prior to the TAA administration as described previously (23 (link)).
+ Open protocol
+ Expand
4

Knockdown of Innate Immune Sensors

Check if the same lab product or an alternative is used in the 5 most similar protocols
HL-60 and THP-1 cells were infected with MISSION lentivirus carrying pLKO.1 puro with shRNA constructs (STING-1: TRCN0000164628; STING2: TRCN0000135555; AIM2-1: TRCN0000107501; AIM2-2: TRCN0000107502; and cGAS: TRCN0000149984), which were purchased from Sigma-Aldrich. Each cell line infected with MISSION lentivirus carrying pLKO.1 puro and with a non-mammalian shRNA control construct was used as a shControl. Stably transfected cells were selected in culture medium supplemented with 1 μg/ml puromycin for more than 2 weeks. For the transient KD of ATG5 gene expression, HL-60 cells were transfected with ATG5 siRNA (Santa Cruz Biotechnology, Santa Cruz, CA, USA) using GENOMONE-Si transfection reagent (Ishihara Sangyo, Osaka, Japan). As a siControl, cells were transfected with control siRNA-A (Santa Cruz Biotechnology). The KD efficiency of each gene was confirmed using quantitative real-time PCR (qRT-PCR) and western blotting analyses.
+ Open protocol
+ Expand
5

ATG5 Knockdown in HT22 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For siRNA transfections, HT22 cells were plated in 60 mm dishes at 5 × 105 cells/dish and 166 pmol ATG5 siRNA (#sc-41446) or control siRNA (#sc-37007), all from Santa Cruz Biotechnology (Santa Cruz, CA), were used along with RNAiMAX (Invitrogen) according to the manufacturer’s instructions.
+ Open protocol
+ Expand
6

Cholesterol Efflux Regulation via AMPK-Dependent Autophagy

Check if the same lab product or an alternative is used in the 5 most similar protocols
RPMI 1640 medium FBS (C0252) was acquired from Beyotime Biotechnology (Shanghai, China). Phorbol‐12‐Myristate13‐acetate (PMA; P1585) and 3‐methyladenine (3MA, 5 mmol/L; M9281) were purchased from Sigma‐Aldrich. RACK1 siRNA (sc‐36354), ATG5 siRNA (sc‐41445), and primary antibodies such as RACK1 (sc‐17754), beclin‐1 (sc‐11427), LC3 (sc‐398822), ABCA1 (sc‐53482), GAPDH (sc‐47724), β‐actin (sc‐47778) and AMPK (sc‐17754) were acquired from Santa Cruz Biotechnology. Other primary antibodies like anti‐AMPK (2793) and anti–phospho‐AMPK Thr172 (2535) from acquired from Cell Signaling Technology, while p62 primary antibody was supplied by R&D Systems. Acetylated LDL (Ac‐LDL; L8940), FGF21 (ab63277) and secondary goat anti‐mouse IgG‐HRP (ab97023) and goat anti‐rabbit IgG (ab205718) antibodies came from Abcam, while pEGFP‐LC3 was supplied by Cell Biolabs.
+ Open protocol
+ Expand
7

Beclin and Atg5 Silencing in LLC-PK1 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
LLC-PK1 cells were seeded in a six-well plate with 5% FBS in M199 medium without antibiotics. Beclin siRNA (sc–29798) and Atg5siRNA (sc–41446) were obtained from Santa Cruz Biotechnology. Cells at 70% confluence were untreated (control) or transfected with the corresponding siRNA pools using Lipofectamine 2000 (Invitrogen) according to the manufacturer’s instructions. Twenty-four hours after transfection, cells were treated as indicated and a portion of the samples were collected to analyze gene silencing by Western blot analysis.
+ Open protocol
+ Expand
8

Fibroblast and HeLa Cell Culture Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
Wild-type mouse embryonic fibroblasts, TBK1+/- mouse embryonic fibroblasts, TBK1-/- mouse embryonic fibroblasts, and HeLa cervical cancer cells were maintained in DMEM growth medium consisting of DMEM supplemented with 10% fetal bovine serum (FBS; Life Technologies; 16010–159) and antibiotic/antimycotic (Life Technologies; 15240–062).
Bafilomycin A1 (Sigma-Aldrich; 19–148) was dissolved in dimethyl sulfoxide (DMSO) at a concentration of 100 mM and cells were treated at a concentration of 100 nM for the times indicated.
ATG5 siRNA (human [Santa Cruz Biotechnology; sc-41445]), IFNAR siRNA (human [Santa Cruz Biotechnology; sc-35637]), GABARAPL1 siRNA (human [Santa Cruz Biotechnology; sc-105386]), GABARAPL2 siRNA (human [Santa Cruz Biotechnology; sc-41958]), and TBK1 siRNA (human [Santa Cruz Biotechnology; sc-39058]) were reconstituted by following the manufacturer-provided datasheet. HeLa cells were transfected using Effectene transfection reagent by following the manufacturer’s guidelines for reagent volumes. Forty-eight hours following transfection, the medium was refreshed and cells were subsequently infected.
+ Open protocol
+ Expand
9

siRNA-mediated LY6D and ATG5 knockdown

Check if the same lab product or an alternative is used in the 5 most similar protocols
ON-TARGETplus Smart Pool siRNA for LY6D (L-012615-01) and its control siRNA (D-001810-10) were from GE Healthcare Dharmacon (Lafayette, CO). ATG5 siRNA (sc-41445) was obtained from Santa Cruz Biotechnology. Cells were seeded and transfected with 30-nM siRNA using HiPerFect Transfection Reagent (Qiagen, Venlo, Netherlands) according to the manufacturer’s instruction.
+ Open protocol
+ Expand
10

Culturing and Analyzing HUVEC Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human umbilical vein endothelial cells (HUVEC) were grown and maintained in basal media supplemented with VascuLife EnGS LifeFactors Kit (Lifeline Cell Technology, Oceanside, CA). Cells were plated on 0.2% (w/v) gelatin-coated cell culture plates (Thermo Fisher Scientific, Waltham, MA) and utilized within the first five passages. Antibodies for Western Blotting (WB) were purchased from the following sources and utilized at the designated dilutions: GAPDH (14C10, 1:10,000 dilution; Cell Signaling, Danvers, MA), LC3B (L7543, 1:1,000 dilution; Sigma), and HAS2 (sc-514737 and sc-365263 at 1:250 and 1:150, respectively; Santa Cruz Biotechnology, Dallas, TX). The following siRNA was purchased from Santa Cruz Biotechnology and used at the designated amounts: ATG5 siRNA (sc-41445, 100 pM) and scramble control siRNA-A (sc-37007, 100 pM).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!